𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In vivo evaluation of [123I]-4-iodo-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies

✍ Scribed by Ludovicus Staelens; Ruth Oltenfreiter; Filip Dumont; Rikki N. Waterhouse; Katia Vandenbulcke; Peter Blanckaert; Rudi A. Dierckx; Guido Slegers

Book ID
116798829
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
303 KB
Volume
32
Category
Article
ISSN
0969-8051

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synthesis and radiolabelling of [123I]-4
Synthesis and radiolabelling of [123I]-4-iodo-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide, a potential dopamine D3 antagonist for SPECT studies
✍ L. Staelens; F. Dumont; F. De Vos; R. Oltenfreiter; M. Vandecapelle; R.A. Dierck 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 95 KB 👁 1 views

## Abstract Schizophrenia is a devastating mental disorder characterized by relapsing psychotic episodes accompanied with emotional, professional and social decline. The classical dopamine hypothesis of schizophrenia postulates that hyperactivity of dopaminergic neurotransmission is responsible for

Synthesis and radiolabelling of [123I]-4
Synthesis and radiolabelling of [123I]-4-iodo-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide, a potential dopamine D3 antagonist for SPECT studies
✍ L. Staelens; F. Dumont; F. De Vos; R. Oltenfreiter; M. Vandecapelle; R. A. Dierc 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 98 KB 👁 1 views

## Abstract Schizophrenia is a devastating mental disorder characterized by relapsing psychotic episodes accompanied with emotional, professional and social decline. The classical dopamine hypothesis of schizophrenia postulates that hyperactivity of dopaminergic neurotransmission is responsible for

6-[123I]Iodo-2-[[4-(2-methoxyphenyl) pip
6-[123I]Iodo-2-[[4-(2-methoxyphenyl) piperazin-1-yl]methyl]imidazo[1,2-a]pyridine as potential SPECT agent for imaging dopamine D4 receptor: synthesis and in vivo evaluation in a nonhuman primate
✍ David Alagille; Andrei O. Koren; Greg Kudej; Julie Staley; Kelly Cosgrove; John 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 129 KB 👁 1 views

## Abstract The dopamine D~4~ receptor subtype has drawn considerable attention due to its potential implication in schizophrenia and erectile dysfunction. 6‐[^123^I]Iodo‐2‐[[4‐(2‐methoxyphenyl)piperazin‐1‐yl]methyl]imidazo[1,2‐__a__]pyridine [^123^I]‐1, a potent and selective new dopamine D~4~ ago

Synthesis and preliminary in vivo evalua
Synthesis and preliminary in vivo evaluation of 4-[18F]fluoro-N-{2-[4-(6-trifluoromethylpyridin-2-yl)piperazin-1-yl]ethyl}benzamide, a potential PET radioligand for the 5-HT1A receptor
✍ M. Vandecapelle; F. Dumont; F. De Vos; K. Strijckmans; D. Leysen; K. Audenaert; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 138 KB 👁 1 views

## Abstract 4‐Fluoro‐__N__‐{2‐[4‐(6‐trifluoromethylpyridin‐2‐yl)piperazin‐1‐yl]ethyl}benzamide is a full 5‐HT~1A~ agonist with high affinity (__pK__~__i__~=9.3), selectivity and a __c__ log __P__ of 3.045. The corresponding PET radioligand 4‐[^18^F]fluoro‐__N__‐{2‐[4‐(6‐trifluoromethylpyridin‐2‐yl)